When AI Needs Faster Pipes, This Supplier Has the Numbers
The market is sitting near records after two calmer inflation reports took some pressure off the Fed. Earnings are doing the real work, though. This week stays below the megacaps and focuses on five companies where demand, guidance, or cash flow just improved.
Tech Edge (Sponsored)
First users could have already grown their money dramatically every single year this AI has been running, based on the average winning trades it uncovers – WITHOUT following market news, WITHOUT watching central banks, and WITHOUT the stress most traders deal with daily.
For a limited time, you can try this AI yourself, completely free – no email, no credit card needed.
Want to make sure you never miss a stock recommendation?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell. Email’s great. Texts are faster.
Coherent (COHR)
Catalyst: AI data-center demand pushed revenue higher, and management guided above Wall Street expectations
The Numbers Keep Getting Bigger
Coherent just delivered another strong quarter. Revenue reached $2.05 billion, ahead of expectations, while adjusted earnings came in at $1.74 per share versus the $1.61 analysts were looking for.
The real story sits inside the data-center business. Revenue from data center and communications reached $1.62 billion, up from $1.02 billion a year earlier. That is nearly 60% growth in the company's largest segment.
Management expects the momentum to continue. Coherent guided for first-quarter revenue of $2.2 billion to $2.4 billion and adjusted earnings of $1.85 to $2.05 per share, both ahead of consensus.
AI Needs Connections Too
Coherent makes optical transceivers and photonics products that move information around data centers. GPUs get the headlines, but thousands of expensive processors are not very useful if data cannot move between them fast enough.
That is why optics has become one of the more interesting second-order AI trades. As computing clusters get larger, the industry keeps moving away from copper and toward higher-speed optical connections.
Nvidia also invested $2 billion in Coherent earlier this year to support manufacturing capacity and research. That is a strong vote of confidence from the biggest customer ecosystem in AI infrastructure.
The Catch
The stock has already had an enormous run. Industrial revenue also fell 16% last quarter, and full-year operating cash flow declined sharply. This is not a business where every segment is firing at once.
My Take: The AI demand is real enough to keep COHR near the top of the watchlist, but the stock needs a better entry. Buy pullbacks rather than chasing another vertical move.
What to watch: Data-center revenue, optical capacity additions, margins, operating cash flow, and whether fiscal 2027 guidance keeps moving higher.
Before It Breaks (Sponsored)
Washington still values its gold at a 1973 price, while real gold sits above $3,100.
Trump could be about to blow that number wide open, and last time this happened, one asset exploded over 2,000 percent.
Get the free report before this breaks.
Cardinal Health (CAH)
Catalyst: Specialty-drug demand drove another earnings beat and an above-consensus 2027 forecast
A Boring Business With Better Numbers
Cardinal Health does not have an AI story, and that is useful right now.
The drug distributor reported adjusted fourth-quarter earnings of $2.91 per share, comfortably ahead of the $2.42 Wall Street expected. Revenue rose 6% to $63.67 billion.
More important, management expects fiscal 2027 adjusted earnings of $12.40 to $12.60 per share, above the roughly $12.04 analysts had penciled in.
Its Pharmaceutical and Specialty Solutions division generated $55.4 billion in quarterly sales, up 6%, helped by strong demand for branded and specialty medicines.
Specialty Drugs Are Changing Distribution
Drug distribution looks like a low-margin business until the product mix changes.
More expensive treatments for cancer, autoimmune diseases, and other complex conditions are increasing the importance of specialty distribution. Cardinal is also expanding beyond simply moving boxes, adding businesses tied to diabetes supplies, urology, and home healthcare.
That gives the company better earnings leverage than its traditional wholesaling reputation suggests.
Capital Returns Help
Cardinal also expects to repurchase $1 billion of stock during fiscal 2027. That adds another earnings tailwind while the underlying specialty business keeps expanding.
My Take: CAH is the steady compounder on this week's list. I would rather buy it on ordinary market weakness than wait for a dramatic selloff that may never arrive.
What to watch: Specialty-drug growth, pharmaceutical margins, acquisition integration, medical distribution volumes, and execution against the new 2027 guidance.
Embraer (EMBJ)
Catalyst: Record quarterly revenue, better margins, and a doubled free-cash-flow forecast
The Quarter Changed the Setup
Embraer reported record second-quarter revenue of roughly $2.23 billion, up 10% from last year. Net profit increased 25%, EBITDA climbed 30%, and the company delivered 65 aircraft during the quarter.
Management then made the report more interesting.
The company doubled its minimum 2026 free cash flow forecast from $200 million to $400 million and raised adjusted EBIT margin guidance from 8.7%–9.3% to 10.0%–10.6%.
That is a meaningful jump in expected profitability.
It Is More Than Commercial Jets
Embraer is the world's third-largest aircraft manufacturer, but the defense business deserves more attention. Defense and Security revenue rose 22%, helped by demand for its KC-390 military transport aircraft.
The company is exploring additional KC-390 assembly capacity in both the United States and India. Bigger international orders would turn defense into a much more important earnings driver.
Commercial aviation has another runway. Embraer aims to produce 110 to 120 aircraft annually by 2030, which would materially expand the business.
Why It Fits This List
Embraer has aerospace exposure without the valuation or market cap of the biggest U.S. defense and commercial-aircraft names. It also has three different growth engines: commercial aviation, executive jets, and defense.
My Take: EMBJ is one of the more interesting industrial growth names under $20 billion. Buy reasonable pullbacks while free cash flow and margins continue moving higher.
What to watch: Aircraft deliveries, KC-390 orders, supply-chain execution, commercial production rates, and free-cash-flow conversion.
Full Breakdown (Sponsored)
On January 7, I met with a man tied to oil deals, intelligence circles, and government insiders.
What he told me changed how I see the Iran conflict.
He says the strikes and chaos may be part of something much bigger.
Click here to see the full breakdown before this story develops further.
Chime Financial (CHYM)
Catalyst: Revenue grew 27%, membership passed 10 million, and management raised guidance
Fintech Is Starting to Produce Profits
Chime is becoming harder to dismiss as just another fintech growth story.
Second-quarter revenue increased 27% to $670 million, ahead of estimates. Active members jumped 20% to 10.4 million, while average revenue per member increased 6% to $260.
Chime also recorded $28 million in net income, marking its second consecutive profitable quarter.
Management now expects 2026 revenue growth of 25% to 26%, compared with Wall Street expectations closer to 23%.
The Customer Base Is Changing
One of the more interesting details is where Chime is finding growth.
Management said its fastest-growing customer group is people earning more than $75,000 per year. That matters because Chime built its brand around younger and lower-balance customers. Moving up the income ladder expands the addressable market and gives the company more products to sell each member.
Payments revenue also increased 21% during the quarter.
One Management Risk
Longtime CFO Matt Newcomb is leaving after a decade with the company. That does not undermine the thesis, but executive turnover deserves attention when a recently public company is shifting from growth-at-all-costs to consistent profitability.
My Take: CHYM is the higher-risk growth idea this week. The combination of 20% member growth and consecutive profitable quarters makes it interesting, but position sizing should reflect the shorter public track record.
What to watch: Member growth, revenue per member, profitability, Chime Prime adoption, and the permanent CFO appointment.
YPF (YPF)
Catalyst: Record profitability, surging shale production, and a $51 billion LNG project
Vaca Muerta Is Starting to Deliver
YPF reported $1.21 billion in second-quarter net income, compared with just $58 million a year ago.
Revenue jumped 42% to $6.57 billion, while adjusted EBITDA reached a quarterly record of $2.80 billion, up 149% year over year.
The production numbers explain the improvement. Shale oil output climbed 47% to an average of 213,000 barrels per day. Management wants to reach 250,000 barrels per day by year-end.
The company also lifted its 2026 EBITDA forecast from $6 billion to $8 billion.
The Bigger Story Is LNG
YPF is now pushing a much larger project.
Along with Eni and XRG, the company has applied for Argentina's investment incentive program for a planned $51 billion LNG development tied to the Vaca Muerta shale formation.
If executed, the project would give Argentina a much larger route into global LNG exports and turn YPF into more than an Argentine oil producer.
The Risk Is Argentina
The upside does not come free.
YPF is controlled by the Argentine government, the project requires enormous capital, commodity prices matter, and political risk is permanently part of the valuation. This stock deserves a discount to similar assets in more predictable jurisdictions.
But the operating numbers are getting difficult to ignore.
My Take: YPF is the highest-macro-risk name on the list, but the earnings growth justifies a speculative position. Keep it smaller and let Vaca Muerta production prove the thesis.
What to watch: Shale production, oil prices, the $8 billion EBITDA target, LNG project approvals, capital spending, and Argentine policy.
Poll: Which earnings report this week are you most focused on as a market signal?
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE SQUEEZE
The defensive sleeve: staples and steady compounders, boring on purpose, built for the nights you'd rather sleep than watch futures.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
Final Word
Smaller Names, Real Numbers
Coherent has AI demand showing up directly in optical revenue. Cardinal Health is turning specialty drugs into higher earnings. Embraer is expanding margins and cash flow across commercial and defense aviation. Chime is pairing strong customer growth with actual profitability. YPF is producing record earnings as Vaca Muerta scales.
The Risks Are Different
Coherent has valuation risk. Cardinal has lower growth. Embraer depends on flawless manufacturing execution. Chime still has a short public history. YPF comes with commodity and political risk.
That is exactly why the list works.
The Takeaway
You do not need another trillion-dollar stock to find growth. Stay below the megacaps, demand real earnings progress, and make sure the catalyst is already showing up in the numbers.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.
